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ABSTRACT: A novel series of ethyl 8-methyl-3,6-diphenyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-
carboxylates 4 (a-m) were synthesized in good to excellent yield via cyclocondensation of  2-amino-5-pheny-6H-
1,3,4-thiadiazine 1 (a-d) with ethyl acetoacetate (2) and various substituted aldehydes 3 (a-d) in presence of p-
toluene sulfonic acid (PTSA) in acetonitrile. The structures of these compounds 4 (a-m) were characterized by IR, 
1H NMR, 13C NMR, Mass spectroscopic techniques and elemental analysis. All newly synthesized compounds 4 
(a-m) were screened for antimicrobial activities. 
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INTRODUCTION 
Multi-component reactions (MCRs) are one-pot processes in which three or more reactants come together in a 
single reaction vessel to give a final product. MCRs is currently an important part of numerous research work 
involved in the drug discoveries to achieve synthetic targets in effective way, because they are easy to carry out, 
and  provide rapid access to libraries of organic compounds with diverse substitution patterns. a) I Ugi et. al., 
1994; b) I Ugi et. al., 2000; c) I  Ugi et. al., 2001; d) C O Kappe, 2002 e) J Zhu and H Bienayne, 2005; f) K 
Kumaravel and G Vasuki, 2009].  These methods eliminate the isolation of intermediates, there by reduces the 
reaction time and increases the yield than the normal multistep methods (M Zhang et. al., 2006). Pyrimidine 
derivatives and heterocyclic annulated pyrimidines continue to attract the great interest because of their wide 
variety of biological activities such as anticancer (C R Petrie et.al., 1985), antiviral (M N Nasr and M M 
Gineinah, 2002) and anti-inflammatory activities (S M Sondhi, et. al., 2001). Pyrimido-[4,5-e][1,3,4] thiadiazines 
have the potential to exhibit distinct biological activities because of being nucleoside analogues (H Ogura, et.al., 
1978).  In 1893, Italian chemist Biginelli reported (P Biginelli, 1893) the simplest and most straightforward 
procedure involves three component one-pot cyclocondensation of the acetoacetic ester, aldehyde and third 
component as urea/thiourea in strong acidic condition to obtain a new compound 3,4-dihydropyrimidin-2(1H)-
ones (or Biginelli compounds). Biginelli compounds like Pyrimidinones or dihydropyrimidinones (DHPMs) are 
biologically active and well known in the field of drug discovery. This stimulated an interest in the synthetic 
methods for their preparation chemical transformations and application. 1,3,4-thiadiazines represents the widely 
studied class of compounds among the six theoretically possible thiadiazine isomers; and  are the most interest in 
a chemical sense because they are capable of undergoing intramolecular rearrangement to give thiazole and 
pyrazole derivatives. In addition 1,3,4-thiadiazines exhibit a broad spectrum of biological activites (S V Usolteva 
et. al., 1991) and in agriculture they act as a herbisides, pestisides, fungisides, insecticides,  plant growth 
regulators, in photography and in dye manufacture. 
The synthesis of some new fused tetrahydropyrimidino[4,5-e] thiadiazine was achieved (M S Chande et. al., 
1999)  by the reaction of thiocarbohydrazide with 5-bromo barbituric acid in presence of pyridine in ethanol. The 
obtained pyrimidino [4,5-e] thiadiazine was treated with different aldehydes afforded the corresponding Schiff’s 
base. A simple one-pot synthesis of new 2-anilino-pyrimido[4,5-e][1,3,4] thiadiazines (M Bakavoli et. al., 2008)  
via an intermediates formed by the reaction of 5-bromo-2-chloro-6-methyl-4-(1-methylhydrazino) pyrimidine 
with various arylisothiocyanates in presence of triethylamine in boiling acetonitrile under nitrogen atmosphere. 
Recently, a series of 5-alkyl-7-chloro-3-phenylazo-1-phenyl-1H-pyrimido[4,5-e] [1,3,4]thiadiazines were 
prepared (M Nikpour et.al., 2012) by condensation of the dithiazone with 5-bromo-2,4-dichloro-6-
alkylpyrimidines in alkaline acetonitrile. 
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Literature survey reveals that, available methods for the synthesis of pyrimido-thiadiazine derivatives involve 
multistep reaction, exhaustive workup and poor yields. So here we communicate a novel method for the synthesis 
of new bicyclo heterocyclic compound containing 1,3,4-thiadiazine fused with pyrimidine moiety i.e., ethyl 8-
methyl-3,6-diphenyl-2,6-dihydropyrimido[2,1-b][1,3,4] thiadiazine-7-carboxylates 4 (a-m). 
 
MATERIALS AND METHODS 
All chemicals/reagents were purchased from Merck Chemicals (India) and Fluka chemicals (India). The melting 
points were measured with micro melting point apparatus and are uncorrected. IR spectra were recorded in KBr 
pellets on Shimadzu 8300 spectrometer. The 1H NMR (CDCl3) was recorded on a Agilent –NMR-vnrms 400 
MHz spectrophotometer and 13C NMR (DMSO-d6) spectra were obtained on a Varian Gemini 400 MHz 
spectrometer.  Chemical shifts are expressed in ppm (TMS was used as internal standard). Mass spectra were 
obtained on Agilent 6330 ion trap spectrophotometer and elemental analysis was performed on a Jusco 
microanalytical data unit. Thin layer chromatography (TLC) was performed on a pre-coated Silica Gel sheets (HF 
254, Sd-fine) and visualization of the spots was done in iodine vapour and/or UV light. Chromatographic 
separations were carried out on silica gel (60-120) mesh using petroleum ether: acetone (9:1) as eluent. 
General procedure for the synthesis of 2-amino-5-phenyl-6H-1,3,4-thiadiazine,  1a : (P K Bose,  1924), (A P 
Novikova, 1921) The solution of phenacyl bromide (2.00g 10.00 mmol) was refluxed with thiosemicarazide 
(0.90g 10.00 mmol) in 20 ml of conc. HCl for about 30 minutes.  After the completion of reaction (monitored 
through TLC), the reaction mixture was cooled to room temperature. The pale yellow solid thus obtained was 
filtered, washed with chloroform (3 X 10 mL), dried and recrystallized from methanol to give 2-amino-5-pheny-
6H-1,3,4-thiadiazine 1a  in 70% yield. 
Typical procedure for the synthesis of ethyl 8-methyl-3,6-diphenyl-2,6-dihydropyrimido[2,1-b][1,3,4] 
thiadiazine-7-carboxylate (4a). 
 
2-amino-5-pheny-6H-1,3,4-thiadiazine (1a, 1.91g, 10.00 mmol), ethyl acetoacetate (2, 1.30g, 10.0 mmol), 
benzaldehyde (3a, 1.06g, 10.00 mmol) and PTSA (2.50g, 15.00 mmol) was dissolved in acetonitrile (30 mL) and 
the resulting solution was refluxed for about 2-3 hr. After the completion of reaction the reaction mixture was 
cooled to room temperature and extracted with CHCl3 (3 X 25 mL), washed successively with water (2 x 25 mL), 
2% dilute HCl solution and dried over anhydrous Na2SO4. The solvent was evaporated to give red viscous liquid, 
which was subjected to chromatographic separation (silica gel (60-120) using ethyl acetate and petroleum ether 
(2:8) as eluent, to get an orange colour solid ethyl 8-methyl-3,6-diphenyl-2,6-dihydropyrimido[2,1-
b][1,3,4]thiadiazine-7-carboxylate (4a) in 75% yield (0.58g) m.p. 148-150ºC. IR (KBr, cm-1): γ 2935 (C-H), 
1610(C=N), 1740 (C=O); 1H NMR (CDCl3): δ 1.25 (t, J = 6.94 Hz, 3H, CH3), 2.42 (s, 3H, CH3), 3.75 (s, 2H 
CH2), 4.22 (q, 2H, J = 7.2Hz, OCH2), 6.41 (s, 1H, CH), 7.06-7.51 (m, 10H, Ar-H); 13C NMR (DMSO-d6): δ 14.2 
(C-14), 21.4 (C-11), 25.8 (C-2), 61.7 (C-13), 66.2 (C-6), 122.9 (C-7), 126.7 (C-24), 126.9 (C-26 and C-22), 128.2 
(C-20 and  C-16), 128.5 (C-23 and C-25), 128.9 (C-19 and C-17), 131.2 (C-18), 134.1 (C-15), 143.4 (C-21), 
154.0 (C-8), 155.6 (C-3), 164.3 (C-10), 167.2 (C-12) ; MS for C22H21N3O2S : 392.15 (MH)+ ;  Anal. % Calcd: C: 
67.50 H: 5.41 N: 10.73; Found: C: 67.40 H: 5.58 N: 10.57. 
Ethyl 6-(4-chloro-phenyl)-8-methyl-3-phenyl-2,6-dihydropyrimido[2,1-b] [1,3,4]-thiadiazine-7-carboxylate 
(4b): Obtained from 2-amino-5-pheny-6H-1,3,4-thiadiazine (1a, 1.90g, 10.00 mmol), ethyl acetoacetate (2a, 
1.30g, 10.00 mmol),  4-chloro-benzaldehyde  (3b, 1.40g, 10.00 mmol) and PTSA (2.50g 15.00mmol) as red solid, 
yield 70% (2.98 g), m.p. 156-158ºC. IR (KBr cm-1): γ 2940 (C-H), 1615 (C=N), 1735 (C=O); 1H NMR (CDCl3): δ 
1.28 (t, J = 6.94 Hz, 3H, CH3), 2.50 (s, 3H, CH3), 3.70 (s, 2H CH2), 4.33 (q, 2H, J = 7.2 Hz, OCH2), 6.51 (s, 1H, 
CH), 7.28-7.62 (m, 9H, Ar-H). 13C NMR (DMSO-d6): δ 14.2 (C-14), 21.5 (C-11), 25.9 (C-2), 61.8 (C-13), 66.2 
(C-6), 123.0 (C-7), 132.5 (C-24), 126.1 (C-26 and C-22), 128.2 (C-20 and C-16), 128. 7 (C-23 and C-25), 129.0 
(C-17 and C-19), 131.3 (C-18), 134.1 (C-15), 141.6 (C-21), 154.1(C-8), 155.7 (C-3), 164.4 (C-10), 167.2 (C-12); 
MS for C22H20ClN3O2S : 426.21 (MH)+. Anal. % Calcd: C: 62.04; H: 4.73; Cl: 8.32; N: 9.87. Found: C: 61.92; H: 
4.88; N: 9.69.  
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Ethyl 8-methyl-3-phenyl-6-p-tolyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-carboxylate (4c): 
Obtained from 2-amino-5-pheny-6H-1,3,4-thiadiazine (1a, 1.90g, 10.00 mmol), ethyl acetoacetate (2a, 1.30g, 
10.00 mmol), 4-methyl-benzaldehyde (3c, 1.24g, 10.00 mmol) and PTSA (2.50g 15.00 mmol) as red solid, yield 
68% (2.76g), m.p. 149-151ºC IR (KBr cm-1): γ 2945 (C-H), 1618(C=N), 1733 (C=O); 1H NMR (CDCl3): δ 1.23 
(t, J = 6.94Hz, 3H, CH3), 2.48 (s, 3H, CH3), 2.52 (s, 3H, CH3), 3.94 (s, 2H CH2), 4.23 (q, 2H, J = 7.2 Hz, OCH2), 
6.51 (s, 1H, CH), 6.96-7.48 (m, 9H, Ar-H); 13C NMR (DMSO-d6): δ 14.3 (C-14), 21.4 (CH3), 21.4 (C-11), 25.8 
(C-2), 61.7 (C-13), 66.2 (C-6), 122.9 (C-7), 136.5 (C-24), 126.8 (C-26 and C-22), 128.2 (C-20 and C-16), 128.9 
(C-23 and C-25), 128.9 (C-17 and C-19), 131.2 (C-18), 134.1 (C-15), 140.3 (C-21),154.0 (C-8), 155.6 (C-3), 
164.3 (C-10), 167.2 (C-12); MS for C23H23N3O2S: 406.11 (MH)+;  Anal. % Calcd: C: 68.12 H: 5.72 N: 10.36; 
Found: C: 68.09 H: 5.81 N: 10.21.  
Ethyl 6-(4-methoxy-phenyl)-8-methyl-3-phenyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7- 
carboxylate (4d): Obtained from 2-amino-5-pheny-6H-1,3,4-thiadiazine (1a, 1.90g, 10.00 mmol), ethyl 
acetoacetate (2a, 1.30g, 10.00 mmol), 4-methoxy-benzaldehyde (3d, 1.36g, 10.00 mmol) and PTSA (2.50g, 15.00 
mmol) as reddish amorphous solid, yield 72% (3.03g). IR (KBr cm-1): γ 2947 (C-H), 1620(C=N), 1730 (C=O); 1H 
NMR (CDCl3): δ 1.25 (t, J = 6.94 Hz, 3H, CH3), 3.74 (s, 3H, OCH3), 2.43 (s, 3H, CH3), 4.14 (s, 2H CH2), 4.22 (q, 
2H, J = 7.2 Hz, OCH2), 6.41 (s, 1H, CH), 6.89-7.48 (m, 9H, Ar-H);  13C NMR (DMSO-d6): δ 14.2 (C-14), 21. 5 
(C-11), 25.8 (C-2), 56.2 (-OCH3), 61.7 (C-13), 66.3 (C-6), 122.8 (C-7), 158.8 (C-24), 125.9 (C-26 and C-22), 
114.3 (C-23 and C-25), 128.2 (C-20 and C-16), 129.0 (C-17 and C-19), 131.3 (C-18), 134.2 (C-15), 136.7 (C-21), 
154.1 (C-8), 155.7 (C-3), 164.4 (C-10), 167.2 (C-12);  MS for C23H23N3O3S: 422.16 (MH)+; Anal. % Calcd: C: 
65.54 H: 5.50 N: 9.97; Found: C: 65.69 H: 5.34 N: 9.61.   
Ethyl 3-(4-methoxy-phenyl)-8-methyl-6-phenyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7- 
carboxylate  (4e) : Obtained from 2-amino-5-(4-methoxy-pheny)-6H-1,3,4-thiadiazine (1b, 2.21g, 10.00 mmol), 
ethyl aceto acetate (2a, 1.30g, 10.00 mmol), benzaldehyde (3a, 1.06g, 10.00 mmol) and PTSA  (2.50g, 15.00 
mmol) as red solid, yield 72% (3.03g), m.p.135-137ºC : IR (KBr cm-1): γ 2950 (C-H), 1615(C=N), 1728 (C=O); 
1H NMR (CDCl3): δ 1.27 (t, J = 6.9 Hz, 3H, CH3), 3.83 (s, 3H, OCH3), 2.46 (s, 3H, CH3), 3.82 (s, 2H CH2), 4.26 
(q, 2H, J=7.2 Hz, OCH2), 6.46 (s, 1H, CH), 6.93-7.51 (m, 9H, Ar-H); 13C NMR (DMSO-d6): δ 14.3 (C-14), 21.5 
(C-11), 25.8 (C-2), 55.9 (-OCH3), 61.7 (C-13), 66.2 (C-6), 123.0 (C-7), 126.8 (C-24), 127.0 (C-26 and C-22), 
128.6 (C-23 and C-25), 128.8 (C-20 and C-16), 114.4 (C-17 and C-19), 162.9 (C-18), 126.4 (C-15), 143.3 (C-21), 
154.0 (C-8), 155.6 (C-3), 164.3 (C-10), 167.1 (C-12);  MS for C23H23N3O3S: 422.10 (MH)+;  Anal. % Calcd: C: 
65.54 H: 5.50 N: 9.97; Found: C: 65.72 H: 5.43 N: 9.64. 
Ethyl 6-(4-chloro-phenyl)-3-(4-methoxy-phenyl)-8-methyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-
carboxylate (4f): Obtained from 2-amino-5-(4-methoxy-pheny)-6H-1,3,4-thiadiazine (1b, 2.21g, 10.00 mmol), 
ethyl aceto acetate (2a, 1.30ml, 10.00 mmol), 4-chloro-benzaldehyde (3b, 1.40g, 10.00 mmol) and PTSA  (2.50g 
15.00 mmoles) as yellow solid, yield 70% (3.19g), m.p.156-158ºC.IR KBr cm-1): γ 2930 (C-H), 1617(C=N), 1726 
(C=O); 1H NMR (CDCl3): δ 1.26 (t, J = 6.94 Hz, 3H, CH3), 3.90 (s, 3H, OCH3), 2.44 (s, 3H, CH3), 4.24 (q, 2H, J 
= 7.2 Hz, OCH2), 3.78 (s, 2H CH2), 6.43 (s, 1H, CH), 6.90-7.53 (m, 8H, Ar-H); 13C NMR (DMSO-d6): δ 14.3 (C-
14), 21.5 (C-11), 25.8 (C-2), 55.9 (-OCH3), 61.7 (C-13), 66.2 (C-6), 122.9 (C-7), 132.5 (C-24), 126.1 (C-26 and 
C-22), 128.7 (C-23 and C-25), 128.8 (C-20 and C-16), 114.4 (C-17 and C-19), 162.9 (C-18), 126.4 (C-15), 143.4 
(C-21), 154.1 (C-8), 156.0 (C-3), 164.3 (C-10), 167.2 (C-12); MS for C23H22ClN3O3S: 456.14 (MH)+. Anal. % 
Calcd: C: 60.59 H: 4.86 N: 9.22; Found: C: 60.66 H: 4.65 N: 9.14. 
Ethyl 3,6-bis(4-methoxyphenyl)-8-methyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-carboxylate (4g): 
Obtained from 2-amino-5-(4-methoxy-pheny)-6H-1,3,4-thiadiazine (1b, 2.21g, 10.00 mmol), ethyl aceto acetate 
(2a, 1.30ml, 10.00 mmol), 4-methoxy-benzaldehyde  (3d, 1.36g, 10.00 mmol) and PTSA (2.5g, 15.00 mmol) as 
reddish pasty mass, yield 71% (3.21g). IR (KBr cm-1): γ 2950 (C-H), 1615(C=N), 1728 (-C=O); 1H NMR 
(CDCl3): δ 1.28  (t, J = 6.94Hz, 3H, CH3), 3.93 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 2.42 (s, 3H, CH3), 4.24 (q, 
2H, J = 7.2 Hz, OCH2), 3.83 (s, 2H, CH2), 6.48 (s, 1H, CH), 6.95-7.58 (m, 8H, Ar-H); 13C NMR(DMSO-d6): δ 
14.3 (C-14), 21.5 (C-11), 25.9 (C-2), 55.9 & 55.9 (OCH3), 61.7 (C-13), 66.2 (C-6), 122.9 (C-7), 158.8 (C-24), 
125.9 (C-26 and C-22), 114.3 (C-23 and C-25), 128.4 (C-20 and C-16), 114.5 (C-17 and C-19), 162.9 (C-18), 
126.4 (C-15), 136.7 (C-21), 154.2 (C-8), 155.7 (C-3), 164.3 (C-10) ,167.3 (C-12);  MS for C24H25N3O4S: 452.14 
(MH)+; Anal. % Calcd: C: 63.84 H: 5.58 N: 9.31; Found: C: 63.91 H: 5.63 N: 9.24;  
Ethyl 3-(4-chlorophenyl)-8-methyl-6-phenyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-carboxylate 
(4h): Obtained from 2-amino-5-(4-chloro-pheny)-6H-1,3,4-thiadiazine (1c, 2.25g, 10.00 mmol), ethyl aceto 
acetate (2a, 1.30g, 10.00 mmol), benzaldehyde (3a, 1.06g, 10.00 mmol) and PTSA (2.50g, 15.00 mmol) as yellow 
solid, yield 67% (2.85g), m.p.134-136ºC. IR (KBr cm-1): γ 2935 (C-H), 1610(C=N), 1735 (C=O); 1H NMR 
(CDCl3): δ 1.28  (t, J = 6.94 Hz, 3H, CH3), 2.55 (s, 3H, CH3), 4.27 (q, 2H, J = 7.2 Hz, OCH2), 3.83 (s, 2H, CH2), 
6.48 (s, 1H, CH), 7.26-7.58 (m, 9H, Ar-H);  
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13C NMR (DMSO-d6): δ 14.3 (C-14), 21.4 (C-11), 25.8 (C-2), 61.8 (C-13), 66.3 (C-6), 123.1 (C-7), 126.7 (C-
24), 126. 9 (C-26 and C-22), 128.5 (C-23 and C-25), 128.1 (C-20 and C-16), 129.0 (C-17 and C-19), 136.6 (C-
18), 132.1 (C-15), 143.5 (C-21), 154.1(C-8), 155.6 (C-3), 164.4 (C-10), 167.2 (C-12);  MS for C22H20ClN3O2S: 
426.11 (MH)+;  Anal. % Calcd: C: 62.04 H: 4.73 N: 9.87; Found: C: 61.94 H: 4.68 N: 9.74.   
Ethyl 3,6-bis(4-chlorophenyl)-8-methyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-carboxylate (4i):  
Obtained from 2-amino-5-(4-chloro-pheny)-6H-1,3,4-thiadiazine (1c, 2.25g, 10.00 mmol), ethyl aceto acetate (2a, 
1.32ml, 10. 00 mmol), 4-chloro-benzaldehyde (3b, 1.40g, 10.00 mmol) and PTSA (2.50g, 15.00 mmol) as bright 
yellow solid, yield 70%, (3.22g), m.p.142-144ºC; IR (KBr cm-1): γ 2928 (C-H), 1615 (C=N), 1724 (C=O); 1H 
NMR (CDCl3): δ 1.26 (t, J = 6.94 Hz, 3H, CH3), 2.53 (s, 3H, CH3), 4.23 (q, 2H, J = 7.2 Hz, OCH2), 3.86 (s, 2H, 
CH2), 6.43 (s, 1H, CH), 7.21-7.52 (m, 8H, Ar-H); 13C NMR(DMSO-d6): δ 14.3 (C-14), 21.5 (C-11), 25.9 (C-2), 
61.9 (C-13), 66.3 (C-6), 123.1 (C-7), 132.5 (C-24), 126.1(C-26 and C-22), 128.7 (C-23 and C-25), 128.2 (C-20 
and C-16), 129.0 (C-17 and C-19), 136.65 (C-18), 132.2 (C-15), 141.2 (C-21), 154.0 (C-8), 155.7 (C-3), 164.4 (C-
10) , 167.25 (C-12); MS for C22H19Cl2N3O2S: 460.31 (MH)+;  Anal. %  Calcd: C: 57.40 H: 4.16 N: 9.13; Found: 
C: 57.26 H: 4.08 N: 9.24.   
Ethyl 3-(4-chlorophenyl)-8-methyl-6-p-tolyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-carboxylate 
(4j): Obtained from 2-amino-5-(4-chloro-pheny)-6H-1,3,4-thiadiazine (1c. 2.25g, 10.00 mmol), ethyl aceto 
acetate (2a, 1.30g, 10.00 mmol), 4-methyl-benzaldehyde (3c, 1.20g, 10.00 mmol) and PTSA (2.50g, 15.00 mmol). 
Pale yellow solid, yield 74% (3.25g), m.p. 147-149ºC. IR (KBr cm-1): γ 2930 (C-H), 1620 (C=N), 1728 (C=O);  
1H NMR (CDCl3): δ 1.25 (t, J = 6.94 Hz, 3H, CH3), 2.47 (s, 3H, CH3), 2.51(s, 3H, CH3), 4.26 (q, 2H, J = 7.2 Hz, 
OCH2), 3.89 (s, 2H,  CH2), 6.51 (s, 1H, CH), 7.26-7.54 (m, 8H, Ar-H); 13C NMR(DMSO-d6): δ 14.3 (C-14), 21.4 
(C-11), 21.5 (-CH3) 25.9 (C-2), 61.8 (C-13),  66.3 (C-6), 123.0 (C-7), 136.5 (C-24), 126.8 (C-26 and C-22), 128.9 
(C-23 and C-25),  128.2 (C-20 and C-16), 128.9 (C-17 and C-19), 136.6 (C-18), 132.1 (C-15), 142.5 (C-21), 
154.1 (C-8), 155.7 (C-3), 164.3 (C-10), 167.20 (C-12); MS for C23H22ClN3O2S: 440.11 (MH)+; Anal. % Calcd: C: 
62.79 H: 5.04 N: 9.55; Found: C: 62.64 H: 5.93 N: 9.61.   
Ethyl 8-methyl-3-(4-Nitrophenyl)-6-phenyl-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-carboxylate 
(4k): Obtained from 2-amino-5-(4-Nitro-pheny)-6H-1,3,4-thiadiazine (1d, 2.36g, 10.00 mmol), ethyl aceto acetate 
(2a, 1.30g, 10.00 mmol), benzaldehyde (3a, 1.064g, 10.00 mmol) and PTSA (2.50g, 15.00 mmol) as  pale yellow 
solid, yield 66 (2.88g)%, m.p. 162-164ºC. IR (KBr cm-1): γ 2938 (C-H), 1718 (-C=O), 1616 (C=N);  1H NMR 
(CDCl3): δ 1.28 (t, J = 6.94 Hz, 3H, CH3), 2.58 (s, 3H, CH3), 4.27 (q, 2H, J = 7.2 Hz, OCH2), 4.14 (s, 2H, CH2), 
6.61(s, 1H, CH), 7.08-7.95 (m, 9H, Ar-H). 13C NMR(DMSO-d6): δ 14.3 (C-14), 21.5 (C-11), 25.9 (C-2), 61.9 (C-
13), 66.3 (C-6), 123.1 (C-7), 126.6 (C-24), 126.9 (C-26 and C-22), 128.5 (C-23 and C-25), 127.8 (C-20 and C-
16), 127.2 (C-17 and C-19), 151.2 (C-18), 140.2 (C-15), 143.4 (C-21),154.3 (C-8), 155.7 (C-3), 164.4 (C-10), 
167.32 (C-12); MS for C22H20N4O4S: 437.15 (MH+); Anal. % Calcd: C: 60.54 H: 4.62 N: 12.84. Found: C: 60.40 
H: 4.48 N: 12.52.   
Ethyl6-(4-chloro-phenyl)-8-methyl-3-(4-Nitro-phenyl)-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-
carboxylate (4l): Obtained from 2-amino-5-(4-Nitro-pheny)-6H-1,3,4-thiadiazine (1d, 2.36g, 10.00 mmol), ethyl 
aceto acetate (2a, 1.30ml, 10.00 mmol), 4-chloro-benzaldehyde (3b, 1.40g, 10.00 mmol) and PTSA (2.50g, 15.00 
mmol) as reddish solid, yield 68% (3.20g), m.p.154 -156ºC. IR (KBr cm-1): γ 2934 (C-H), 1626 (C=N), 1736 
(C=O); 1H NMR (CDCl3-d3): δ 1.27 (t, J = 6.94 Hz, 3H, CH3), 2.57 (s, 3H, CH3), 4.27 (q, 2H, J = 7.2 Hz, OCH2), 
4.17 (s, 2H, CH2), 6.54 (s, 1H, CH),7.04-7.95 (m, 8H, Ar-H); 13C NMR (DMSO-d6): δ 14.4 (C-14), 21.5 (C-11), 
25.9 (C-2), 61.8 (C-13), 66.3 (C-6), 123.1 (C-7), 132.5 (C-24), 126.1 (C-26 and C-22), 128. 7 (C-23and C-25), 
127.9 (C-20 and C-16), 127.2 (C-17 and C-19), 151.2 (C-18), 140.2 (C-15), 141.5 (C-21), 154.0 (C-8), 155.6 (C-
3), 164.5 (C-10), 167.26 (C-12); MS for C22H19ClN4O4S: 471.10 (MH)+; Anal. % Calcd: C: 56.11 H: 4.07 N: 
11.90; Found: C: 55.94 H: 4.17 N: 11.61. 
Ethyl 6-(4-methox-yphenyl)-8-methyl-3-(4-Nitro-phenyl)-2,6-dihydropyrimido[2,1-b][1,3,4]-thiadiazine-7-
carboxylate (4m):  Obtained from 2-amino-5-(4-Nitro-pheny)-6H-1,3,4-thiadiazine (1d, 2.36g, 10.00 mmol), 
ethyl aceto acetate (2a, 1.30g, 10.00 mmol), 4-methoxy-benzaldehyde (3d, 1.36g, 10.00 mmol) and PTSA (2.50g, 
15.00 mmol) as yellowish red gummy mass, yield 70% (3.26g). IR (KBr cm-1): γ 2925 (C-H), 1625 (C=N), 1720 
(C=O); 1H NMR (CDCl3): δ 1.23 (t, J = 6.94 Hz, 3H, CH3), 2.54 (s, 3H, CH3),  3.95 (s, 3H, OCH3), 4.27 (q, 2H, J 
= 7.2Hz, OCH2), 4.21 (s, 2H, CH2), 6.51 (s, 1H, CH), 7.02-8.05 (m, 8H, Ar-H); 13C NMR (CDCl3-d6): δ 14.3 (C-
14), 21.6 (C-11), 25.9 (C-2), 55.9 (-OCH3), 61.8 (C-13), 66.2 (C-6), 122.9 (C-7), 158.8 (C-24), 125.8 (C-26 and 
C-22), 114.3 (C-23 and C-25), 127.9 (C-20 and C-16), 127.2 (C-17 and C-19), 151.2 (C-18), 140.2 (C-15), 135.7 
(C-21), 154.0 (C-8), 155.7 (C-3), 164.4 (C-10), 167.8 (C-12); MS: 467.14 (MH)+;  Anal. % Calc for 
C23H22N4O5S: C: 59.22 H: 4.75 N: 12.00; Found: C: 59.04 H: 4.57 N: 11.81;  
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Antimicrobial activity 
The newly synthesized compounds 4 (a-m) were screened for in vitro anti-bacterial activity against Bacillus 
cereus (MTCC 8372), Staphylococcus aureus (MTCC 96) (gram positive bacteria) Escherichia coli (MTCC 724) 
and Klebsiella pneumonia, (gram negative bacteria) using the agar disc diffusion method. (J M Andrews, 2008). 
The  compounds 4 (a-m) were dissolved in dimethylformamide (DMF) at the concentration 50 and 100µg/mL and 
placed on the inoculated plates, after allowing at 4ºC for 2h, they were incubated at 37ºC for 24h. The inhibition 
zone was measured in millimetres. Tetracycline was used as the standard drug. In addition in vitro antifungal 
screening (J R Zgoda and J R Porter, 2001) of the synthesized compounds 4 (a-m) was carried out against 
Aspergillus flavus (MTCC 873), Aspergillus niger (MTCC 281), Fusarium oxysporum (MTCC 284), and 
Fusarium monaliforme (MTCC 156) using Nystatin as standard drug. The micro dilution method was used to 
evaluate the minimum inhibitory concentration (MIC) of all the synthesized compounds as summarized in Table-
1. The compounds were stable in the Nutrient agar and Potato dextrose agar. The MIC for fungal strains was 
performed using 96-well plate. The fungi were maintained on potato dextrose agar (PDA) medium at 28ºC. Six 
replicate determinations were performed for all the compounds and the results were taken as a mean of at least 
three determinations. 
 
RESULTS AND DISSCUSSION 
The synthesis of ethyl 8-methyl-3,6-diphenyl-2,6-dihydropyrimido [2,1-b][1,3,4] thiadiazine-7-carboxylate 
derivatives 4 (a-m) in excellent yield was achived by the cyclocondensation reaction of 2-amino-6H-1,3,4-
thiadiazines14,15 1 (a-d) with ethyl acetoacetate (2) and various substituted aldehydes 3 (a-d) in presence of 























1a : R1 = H,
1b : R1 = p-OCH3-,
1c : R1 = p-Cl,
1d : R1 = p-NO2-
3a : R2 = H,
3b : R2 = p-Cl,
3c : R2= p-CH3-,
3d : R1 = p-OCH3-
4a : R1 = H, R2 = H, 4h : R1 = p-Cl-, R2 = H,
4b : R 1 = H, R2 = p-Cl, 4i : R1 = p-Cl-, R2 = p-Cl-,
4c : R1 = H, R2 = p-CH3-, 4j : R1 = p-Cl-, R2 = p-CH3-,
4d : R 1 = H, R2 = p-OCH3-, 4k : R1 = p-NO2-, R2 = H,
4e : R1 = p-OCH3-, R2 = H, 4l : R1 = p-NO2-, R2 = p-Cl,
4f : R1 = p-OCH3-, R2 = p-Cl, 4m : R1= p-NO2-,R2 = p-OCH3-,
4g : R1 = p-OCH3-, R2 = p-OCH3-,
Acetonirile
 
The tentative mechanism for the above reaction is as shown in Scheme 2. Initially the in situ preparation of 
intermidate [1] was achieved by the reaction of substituted aldehydes with ethyl acetoacetate in presence of 
PTSA. Further 2-amino-6H-1,3,4-thiadiazine 1 (a-d) reacts with intermediate [1] with the elimination of water 
molecule to yield the corresponding dihydropyrimido [2,1-b][1,3,4] thiadiazine-7-carboxylate 4 (a-m).  
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The newly synthesized compounds were characterized by their IR, 1H NMR, 13C NMR, Mass and elemental 
analysis. For instance, the IR spectra of 4 (a-m) showed the stretching vibration bands at around 2925-2950 cm-1 
corresponding to presence of -CH- group, and a vibration band 1718-1740 cm-1 indicates the  presence of  >C= O 
group in the compound. The 1H NMR spectra of compounds 4 (a-m) in showed, the signals due to C–CH3 proton  
in the region δ 2.40-2.61 ppm, multiplet peaks of ester group, like quatret peak appeared in the region δ 4.21-4.27 
ppm due to-CH2-CH3, and triplet peak due to –CH2-CH3 appeared at δ 1.23-1.28ppm, while singlet peak of  -CH- 
group appeared in the region δ 6.41-6.62 ppm and aromatic protons at δ 6.89-8.10 ppm. Absence of singlet peak 
of –NH2 in the region δ 8.50-9.10 ppm confirms the formation of condensed adduct. In 13C NMR spectra presence 
of additional peaks in the range of  δ 14.2- 14.4 ppm (C-14), 21.4-21.6 ppm (C-11), 61.7-61.9 ppm (C-13), 66.2-
66.3 (C-6) was observed. All synthesized compounds 4 (a-m) showed MH+ as a base peak in the mass spectra. 
 
Table 1: The minimal inhibitory concentration (MIC), minimal bactericidal concentration (MBC) and 
minimal fungicidal concentration (MFC) in µg/mL of synthesized compounds against tested strains. 
 
Compds 
Antibacterial activity Antifungal activity 
Gram positive Gram negative 
B. cereus S. aureus E. coli K. 
pneumonia 




MIC MBC MIC MBC MIC MBC MIC MBC MIC MFC MIC MFC MIC MFC MIC MFC 
4a 85 280 80 260 85 250 90 265 65 250 55 265 60 270 75 280
4b 60 230 80 255 80 260 85 250 25 135 10 120 20 125 15 120 
4c 60 250 45 255 55 260 50 240 60 290 65 285 50 280 60 275 
4d 10 130 15 135 15 140 15 135 10 125 20 120 20 130 15 145 
4e 35 195 50 215 35 220 45 220 35 215 40 220 45 210 50 215 
4f 20 150 25 165 40 210 35 195 45 235 50 220 40 210 55 230 
4g 40 120 15 125 10 120 15 130 30 190 25 175 20 165 15 120 
4h 80 280 95 275 85 285 90 270 75 265 85 295 70 280 90 300 
4i 75 290 90 295 85 280 80 295 95 290 85 280 65 270 70 295 
4j 65 280 85 290 90 275 80 270 25 135 30 155 20 140 45 165 
4k 80 280 90 270 95 285 85 280 85 270 80 280 65 245 25 115 
4l 30 180 35 195 85 295 70 280 90 285 95 275 50 280 55 260 
4m 95 270 80 275 70 265 65 250 80 275 75 260 80 270 65 285 
Tetracycline 5 120 10 120 12 120 8 120 --- --- --- --- --- --- --- --- 
Nystatin --- --- --- --- --- --- --- --- 08 100 10 100 15 100 12 100 
a(Mean six replicate ± standard deviation). 
Structure activity relationship: 
The novel series of 4 (a-m) contains pyrimidine moiety (which is one of the nucleosidic base) and hence a good 
antimicrobial activity was expected, the results revealed that, compounds 4d, 4f, 4g and 4l exhibit good to potent 
antimicrobial activity. Of the five tested bacterial strains, gram-positive bacteria were inhibited mostly by 
compounds 4d, 4f and 4g which containsOCH3 group along with Cl on the para position of the phenyl ring. While 
the gram-negative bacteria were inhibited by compound 4g which contains only OCH3 group at the para position 
of both the phenyl rings of thiadiazine and pyrimidine moiety. Compound 4d and 4g, showed excellent 
antimicrobial activity against all the tested strains of microbes, this may be due to the presence of OCH3 group on 
both the phenyl rings of thiadiazine as well as pyrimidine moieties. The compound 4l containing NO2 do not 
contribute much to the antimicrobial activity against both the strains. With these above findings we conclude that 
the presence of electron withdrawing group like NO2 group is not effective enough to inhibit the growth of 
microbes. The compounds 4b and 4j containing –Cl group were less active against bacterial strains but they 
possess good antifungal activity. While the compounds 4e and 4f showed moderate activity. Except the compound 
4k, the remaining compounds showed less activity against Fusarium monaliforme.  
 
CONCLUSION 
In conclusion, we have achieved the synthesis of novel bicyclic pyrimido thiadiazine derivatives 4 (a-m) through 
an efficient one pot three component chemical transformation. All the synthesized compounds 4 (a-m) have been 
investigated for their in vitro antimicrobial activity. Accordingly, these novel series of bicyclo pyrimido 
thiadiazine analogues emerged as a potent antibacterial and antifungal agents. Among the synthesized 
compounds, 4g showed excellent antimicrobial activity in comparison with standard drug. Hence, it could be a 
promising drug candidate for microbial infections.  
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